Cognizant ties up with Sikka's Vianai Systems - Times of India

[ad_1]
Cognizant and Vishal Sikka-founded Vianai Systems launched a strategic go-to-market partnership to accelerate generative AI offerings. This partnership leverages Vianai's hila Enterprise platform alongside Cognizant's Neuro AI, creating a seamless, unified interface to unlock predictive, AI-driven decision making. For both companies, this partnership is expected to enable growth opportunities in their respective customer bases, and through Cognizant's plans to resell Vianai solutions.
Vianai's hila Enterprise provides clients a platform to safely and reliably deploy any large language model (LLM), optimized and fine-tuned to speak to their systems of record – both structured and unstructured data, enabling clients to better analyze, discover and explore their data leveraging the conversational power of generative AI.
In addition, the LLM monitoring capabilities within hila Enterprise (vianops) is a next-generation monitoring platform for AI-driven enterprises, which monitors and analyzes LLM performance to proactively uncover opportunities to continually improve the reliability and trustworthiness of LLMs for clients.
"In every business around the world, there is a hunger to harness the power of AI, but serious challenges around hallucinations, price-performance and lack of trust are holding enterprises back. That's why we built hila Enterprise, a platform that delivers trusted, human-centered applications of AI," said Dr. Vishal Sikka, founder and CEO of Vianai Systems. "We are excited to work with Cognizant to bring trusted, hallucination-free applications of generative AI to enterprises around the world. I am, as always, passionate about the possibilities of AI for India, especially in the grassroots, and from India for the world. Our partnership with Cognizant will also help to accelerate this and make it a reality," he said.
"Being able to monitor and improve LLM performance is critical to unlocking the true power of generative AI," said Cognizant CEO Ravi Kumar S. "With Vianai's platform and our Neuro AI platform, we believe we will be able to offer our clients a high-quality solution to support seamless data analysis with predictive decision-making capabilities."
[ad_2] Source link https://worldnews2023.com/business/cognizant-ties-up-with-sikkas-vianai-systems-times-of-india/?feed_id=302649&_unique_id=6644eb7986942

Comments

Post a Comment

Popular posts from this blog

Real Housewives of Beverly Hills couple Kyle Richards and Mauricio Umansky ‘seperate’

Image
[ad_1] Stay ahead of the trend in fashion and beyond with our free weekly Lifestyle Edit newsletter Stay ahead of the trend in fashion and beyond with our free weekly Lifestyle Edit newsletter Real Housewives of Beverly Hills ’ Kyle Richards and Mauricio Umansky have reportedly separated after 27 years of marriage. Richards joined the popular Bravo reality series in 2010 with Umansky making regular appearances over the last 13 years. “Kyle and Mauricio have been separated for a while now but are still living under the same roof. They remain amicable as they figure out what’s next for them and their family,” a source confirmed to People on Monday (3 July). The separation will affect both Real Housewives , which is gearing up for its 13th season, and the Netflix reality series Buying Beverly Hills, which follows Umansky’s real estate business as two of their daughters work as agents. Richards has already filmed the second season of the Netflix show, according to Deadline . The I
Read more

Pfizer RSV vaccine for infants has 'generally favorable' safety data, FDA staff say

Image
[ad_1] Blood sample for respiratory syncytial virus (RSV) test Jarun011 | Istock | Getty Images U.S. Food and Drug Administration staff on Tuesday said Pfizer's vaccine that protects infants from respiratory syncytial virus has "generally favorable" safety data. The FDA staff made the conclusion in briefing documents ahead of a meeting on Thursday when a panel of external advisors to the agency will discuss whether to recommend full approval of the RSV shot . The advisors will vote on whether Pfizer's late-stage clinical trial data on the vaccine supports its safety and efficacy. The FDA typically follows the advice of its advisory committees, but is not required to do so. The agency is slated to make a decision on whether to clear the shot in August before RSV season in the fall. If approved, Pfizer's jab would become the world's first vaccine that protects infants against RSV.  RSV usually causes mild, cold-like symptoms. But infants and older ad
Read more

Casemiro has improved Man Utd: Maguire | The Express Tribune

Image
[ad_1] LONDON: Casemiro scored twice as Manchester United turned on the style to beat 10-man Reading 3-1 and reach the FA Cup fifth round on Saturday as Tottenham forward Son Heung-min ended his recent goal drought. On a day lacking major shocks, there were wins for Premier League strugglers Leeds, Leicester and Southampton but Fulham were held by Championship side Sunderland. United – fourth in the Premier League and within touching distance of a place in the League Cup final – produced more compelling evidence they are back on track under new manager Erik ten Hag . The home side took the lead at Old Trafford in the 54th minute when Anthony produced a defence-splitting pass to find Brazil teammate Casemiro, who lifted the ball over goalkeeper Joe Lumley. Four minutes later United were two up, when Casemiro let fly with a stunning strike from outside the box to find the bottom corner. With the home side brimming with confidence, substitute Fred produced an audacious flic
Read more